Ellen Fremion, MD, explains how pediatricians can prepare children with medical complexity for adult care and address gaps in services and support.
News|Articles|June 3, 2026
Top 5 pediatric health headlines you missed in May 2026
Author(s)Morgan Ebert, Executive Editor
Fact checked by: Benjamin P. Saylor
Take a quick look at everything you may have missed in May, including the top FDA approvals and latest clinical updates.
Advertisement
Advertisement
In this monthly recap, Contemporary Pediatrics reviews the most significant developments shaping pediatric practice and public health. Click each title below for full coverage.
Related to this article
In a home-based crossover study, 15 minutes of tablet video before bed did not suppress melatonin or alter sleep in toddlers aged 15-24 months.
AHA, AAP, ACOG, and SMFM issued a Female Life Stage framework that starts cardiovascular risk assessment at perimenarche, around ages 8 to 15.
In PROGRESS Cohort 2, zilurgisertib reduced total HO volume vs placebo at 24 weeks in children aged 6 to 11 with FOP, with no new HO lesions.
A four-dose 25-valent PCV series elicited responses to all 25 serotypes in infants, with serotype 3 GMCs ~15-fold higher than PCV20 after dose 4.
Registry data presented at ASN Kidney Week 2026 linked SCD-PED to higher 90-day survival vs historical controls in pediatric sepsis-associated AKI.
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
The FDA approved insulin icodec-abae for children 10+ with T2D, based on adult ONWARDS data and a single-dose pediatric pharmacokinetic study.
Advertisement
Advertisement